Meet the team

Frank Cheng

Chief Executive Officer

Led multiple digital health companies during last twenty years. Held executive positions with publicly traded companies (GE, Roche, Hillrom, Stereotaxis) and led two venture-backed companies as CEO.  Most recently President & CCO of diagnostic company with autonomous AI technology that was FDA-cleared, Medicare-reimbursed, supported by a new Category 1 CPT code, and adopted around the world.

Prof. Charalambos Antoniades

Co-founder & Chief Scientific Officer

MD PhD FESC Pioneered the research on the relationship between adipose tissue and the cardiovascular system, with specific interest in non-invasive imaging of inflammation. This knowledge has been applied in a variety of diseases, ranging from cardiovascular disease to COVID-19. Deputy Head of the Division of Cardiovascular Medicine at the University of Oxford, and Chair of the British Atherosclerosis Society.

Prof. Keith Channon

Co-founder & Chief Medical Officer

Clinical interventional cardiologist and highly experienced research leader in cardiometabolic disease and risk. Professor at the University of Oxford, with expertise in healthcare innovations in the NHS through NIHR and Director of Academic Health Science Centre.

Dr. Cheerag Shirodaria

Co-founder and Chief Development Officer

MBBS MD MBA FRCP Has been involved in cardiovascular research for more than 25 years. Was General Manager for Medical Devices & Diagnostics and Cardiovascular Therapeutic Area Head at Covance. Is an Honorary Consultant Cardiologist at Oxford University Hospitals NHS Foundation Trust.

Prof. Stefan Neubauer

Co-founder & Chief Translational Officer

MD FRCP FACC FMedSci FSCMR Devoted his work to the development and application of novel imaging techniques in MRI and spectroscopy, and most recently in coronary CT. Head of the Division of Cardiovascular Medicine and Director of the Oxford Centre for Clinical Magnetic Resonance Research (OCMR) at the University of Oxford and Past President of the Society for Cardiovascular Magnetic Resonance (SCMR).

Dr Pete Tomlins

Head of Innovation & Research

PhD, CPhys Chartered Physicist with over 20 years’ research experience in National Labs, academia, and university spin-out. Pete has led technology research programmes, run a data science consultancy, and built prototype medical imaging systems from the ground up. He is passionate about improving health outcomes with data and AI.

Tamsin Crane

General Counsel

PhD Corporate and commercial solicitor with extensive experience advising emerging and established companies on commercial contracts, protection of intellectual property rights, regulatory and corporate governance matters, strategic relationships and financings

Serge Bellon

Chief Commercial Officer

Over 30 years of experience in medical imaging and devices, mostly in the cardiovascular field, including assignments in Japan and the USA. Held marketing, sales and general management positions in start-up and multinational companies.

James Davis

Head of Quality and Regulatory

Over 20 years experience working with medical devices at large multinational companies as well as startup and SMEs. Responsible for regulatory compliance and quality management, has set up a combined management system compliant to ISO 9001, 13485 and 27001 requirements.

Chris Knox

Head of Engineering

BEng (Hons) CEng MIET Accomplished and influential senior leader with a proven track record of over 27 years in the delivery of commercially successful world first, globally deployed, mixed technology medical devices. Demonstrable leadership experience in scaling teams and environments for profitable growth. A strong passion for delivering a shared vision through others.